Back to Search
JACOB FITZPATRICK, PHARMD
PHARMD
Pharmacist
NPI: 1922733948Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
24466(IA)
Research & Publications (20)
Awareness of prostate cancer among patients and the general public: results of an international survey.
PMID 19621026·Prostate Cancer Prostatic Dis·2009
8-other
Long-term persistence and spectral blue shifting of quantum dots in vivo.
PMID 19518087·Nano Lett·2009
7-preclinical
Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device.
PMID 19327526·J Thorac Cardiovasc Surg·2009
4-observational
Reduced heterozygosity impairs sperm quality in endangered mammals.
PMID 19324650·Biol Lett·2009
7-preclinical
Prostate-specific antigen kinetics in localized and advanced prostate cancer.
PMID 19210674·BJU Int·2009
6-review
Female promiscuity promotes the evolution of faster sperm in cichlid fishes.
PMID 19164576·Proc Natl Acad Sci U S A·2009
7-preclinical
Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support.
PMID 19059108·J Heart Lung Transplant·2008
8-other
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach.
PMID 18723368·Crit Rev Oncol Hematol·2008
6-review
Management of localized prostate cancer in senior adults: the crucial role of comorbidity.
PMID 18307688·BJU Int·2008
6-review
Optimizing the management of prostate diseases: prostate cancer. Introduction.
PMID 18307684·BJU Int·2008
8-other
Is hormone ablation still the right choice for advanced prostate cancer?
PMID 17594357·BJU Int·2007
4-observational
Which BPH treatment is the most clinically efficacious and cost-effective?
PMID 17502890·Nat Clin Pract Urol·2007
8-other
Should combination therapy be standard for benign prostatic hyperplasia?
PMID 16474525·Nat Clin Pract Urol·2005
8-other
'Urology: Today's Advances, Tomorrow's Clinical Practice', Cannes, November 2003. Current thinking in prostatic diseases: insights into dual 5alpha-reductase inhibitor therapy in BPH and prostate cancer.
PMID 15175660·Prostate Cancer Prostatic Dis·2004
8-other
Chemoprevention for prostate cancer: the Prostate Cancer Prevention Trial.
PMID 12930412·BJU Int·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3003 US-61, PHARMACY DEPARTMENT
MUSCATINE, IA 52761 - Phone
- (563) 262-3755
Quick Facts
- NPI
- 1922733948
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile